Who visits World Heritage? A comparative analysis of three cultural sites

Heritage tourism is a growing segment of the modern tourism industry, and several studies have been undertaken to identify the individuals who participate in this type of tourism. These have indicated that heritage tourists, generally, are middle class, middle age, and well educated. However, despite their iconic role, there has been relatively little attention paid to profile of visitors to World Heritage Sites. This study aims to better understand the demography of this specific tourism segment through the use of survey-based research at three geographically diverse World Heritage Sites: Independence Hall in the USA, Studenica Monastery in Serbia, and the Archaeological Site of Volubilis in Morocco. Through the use of descriptive statistics, several over-arching trends were noted among the three sites. World Heritage Site visitors were found to be very well educated, but they did not have any similarities in relation to age, income, or residence, which contrasts the “general” heritage tourist typology. However, there were several World Heritage specific trends. While this work is a snapshot of the three sites under study and thus is difficult to generalize, it provides the basis for more comprehensive demographic research on visitors to World Heritage Sites

Residents’ perception of cultural heritage in terms of job creation and overtourism in Europe

In 2017, about 45% of the European population believed that cultural heritage has a positive effect on the local economy and that there are not too many tourists. However, about 33% of Europeans consider the number of tourists to be too high while simultaneously recognizing cultural heritage’s positive impact on the local economy. Based on Flash Eurobarometer data, this article employs a bivariate probit model to estimate the characteristics of both the perception of tourism as a threat to heritage and as a benefit to the local economy. The results show that people who live near cultural sites, who are highly educated, and those with a higher social status are more likely to believe that tourism poses a threat to heritage while also having a positive impact on the local economy. The findings provide data-based support for the assertion that tourism itself is not the problem

World Heritage as a placebo brand: A comparative analysis of three sites and marketing implications

The UNESCO World Heritage List is often regarded as a successful tourism brand that motivates site nominations. However, there is relatively little research dealing specifically with World Heritage (WH) brand attraction effects, and what does exist shows conflicting results. There is a significant research gap in terms of awareness of the WH brand and its potential impact on visitation, which this study seeks to fill through a comparative analysis of three diverse case studies: Independence Hall, USA; Studenica Monastery, Serbia; and the Archaeological Site of Volubilis, Morocco. Survey data (n=771) from these three sites was collected and analyzed resulting in three distinct clusters of visitors. One of the clusters does exhibit higher levels of awareness of the WH brand, but members of this group were not motivated by this knowledge when planning their site visit. It is concluded that the WH brand may function as a placebo, and that its importance may be tied more to political interests than economic advancement. Thus, dependency on the WH List for tourism development may potentially be detrimental for locations in the long-term. The WH brand’s placebo effect could result in long-term problems for both the site and those whose livelihoods depend on tourism

Place attachment and post-disaster decision-making in a second home context: A conceptual framework

As a result of global climate change, natural disasters are becoming more common. However, to date, there has been almost no discussion on second homeowners and disasters, even though second homes are often found in areas that are more prone to natural hazards, i.e. mountainous and coastal regions. In order to develop suitable disaster planning, it is necessary to understand how the impacted individuals respond to disasters. To address this issue, this work presents a conceptual framework that emphasises the importance of place attachment to the post-disaster decision-making process of second homeowners. Due to the absence of literature on this specific topic as well as on second homes and disasters in general, a comprehensive review of the literature from a variety of fields, including tourism, environmental psychology, housing studies, and disaster studies, has been utilized to develop this framework. The resulting framework highlights the centrality of place attachment in this process with its interactions with risk awareness and external factors resulting in three potential final decisions: relocate, return, or return and adapt. As second homeowners can be an integral part of the local and regional economy, an understanding of this process is essential to ensure they are adequately supported post-disaster

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention